ED Initiated Buprenorphine for Opioid Use Disorder | DEA MATE Act Training Course

In this session, Gail D’Onofrio, MD, discusses her pioneering work in creating the evidence for initiating ED buprenorphine treatment with ED patients presenting with opioid use disorder. Topics covered will include: Data supporting the use of buprenorphine in the ED setting as well as the consequences of not initiating treatment, barriers to implementation of ED buprenorphine, and components of successful integration of an ED program with community partnerships. Dr. D’Onofrio also presents current research by emergency physicians regarding innovative strategies such as high-dose buprenorphine inductions and use of extended release 7-day formulation of buprenorphine.
Claim CE credit at: stanford.cloud...
Meet your MATE Act education requirements with over 16 hours online accredited videos and interactive modules. This program applies to most healthcare providers that hold a DEA license. Learn more at med.stanford.e...
For more information visit us at cme.stanford.edu